Oslo, Norway, 5 November 2013 - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces that members of its executive management team will participate in the following upcoming investor conferences:
Credit Suisse Healthcare Conference 2013
Date: 12-14 November 2013
Participants:
Jeff Albers (President, Algeta US)
Mike Booth (SVP, Communications)
Venue: Scottsdale, AZ, USA

DNB Markets Health Care Conference
Date: 27 November 2013
Participants:
Andrew Kay (President & CEO)
Thomas Ramdahl (Executive VP and COO)
Venue: Oslo, Norway

Deutsche Bank dbAccess Pharmaceutical Corporate Day
Date: 5 December 2013
Participants:
Andrew Kay (President & CEO)
Mike Booth (SVP, Communications)
Venue: London, UK

SEB Securities Best of Norway Day
Date: 12 December 2013
Participants:
Mike Booth (SVP, Communications)
Venue: New York, NY, USA

Presentations, where applicable, will be available to download at www.algeta.com following these events.

###

For further information, please contact:

Mike Booth +1 646 410 1884
Communications & Corporate Affairs ir@algeta.com
Media enquiries:
Mark Swallow +44 207 638 9571
Citigate Dewe Rogerson mark.swallow@citigatedr.co.uk
Knut Ekern +47 22 04 82 00
Gambit Hill & Knowlton knut.ekern@hkstrategies.com
Kari Watson +1 781 235 3060
MacDougall Biomedical Communications kwatson@macbiocom.com
Investor enquiries:
Tricia Truehart +1 646 378 2953
The Trout Group ttruehart@troutgroup.com

About Algeta

Algeta is a company focused on developing, manufacturing and marketing novel targeted therapies for patients with cancer. The Company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please visit www.algeta.com.

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

distributed by